Back to search

Article

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study

2026-01-16

Abstract excerpt

<h4>Background</h4> Pulmonary embolism (PE) is frequently suspected in patients with cancer due to non-specific symptoms suggestive of PE and their inherent risk of venous thromboembolism (VTE). Commonly used clinical decision rules (CDRs) and D-dimer testing may be less reliable in this specific population. Due to the lack of guideline recommendations on the optimal diagnostic approach and the perceived futility...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d123489d-28b3-51a9-b1f4-7bb63e371f23
DOI
10.64898/2026.01.14.26344055
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra StudyDOI 10.64898/2026.01.14.26344055
Comparing ‘clinical hunch’ against clinical decision support systems (PERC Rule, Wells score, revised Geneva score and YEARS criteria) in the diagnosis of acute pulmonary embolism.Semantic proximity
Comparative Analysis of the Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Infection on the Performance of Clinical Decision‐Making Algorithms for Pulmonary EmbolismSemantic proximity
A nomogram for predicting pulmonary embolism based on clinical characteristics and laboratory indicators in patients with venous thromboembolismSemantic proximity
Acute pulmonary embolism in patients presenting pulmonary deterioration after admission to internal medicine wards for non-critical COVID-19.Semantic proximity
GIVE-VTE-3: a simple three-component score for venous thromboembolism risk stratification in gastrointestinal cancers - a cross- sectional development study GIVE-VTE-3: VTE risk score in GI cancersSemantic proximity
Ability of Caprini and Padua Risk-Assessment Models to Predict Venous Thromboembolism in a Nationwide StudySemantic proximity
Concise Review of the Clinical Approach to the Exclusion and Diagnosis of Pulmonary Embolism in 2020.Semantic proximity
Optimizing Venous Thromboembolism Risk Management through the PDCA Cycle: A Single-Center Before-and-After Controlled StudySemantic proximity
Incidence, risk factors, and outcome of advanced NSCLC patients receiving antiangiogenic therapy with thromboembolic events: a retrospective cohort studySemantic proximity
Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic Emergence of different phenotypes of thrombotic disease?Semantic proximity
Interpretable Machine Learning and Point-of-Care Digital Risk Stratification for Pneumothorax Following Lung Tumor Ablation: A Multicenter Validation StudySemantic proximity
High-Accuracy Identification of Asymptomatic Pulmonary Embolism Using Neutrophil-to-Lymphocyte Ratio (NLR), Systemic Immune-Inflammation Index (SII), Geneva Original Score, Smoking Duration, Thrombus Location, and Hypertension History: A Single-Center Retrospective Cohort StudySemantic proximity
Select a neighboring publication to make it the new centre.